Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Behrang Alipour"'
Autor:
Soudabeh Farhangi, Behrang Alipour Abedi, Ahmad Firouzan, Abbas Basiri, Behzad Einollahi, Nasser Simforoosh, Mohsen Nafar, Fatemeh Pour-Reza-Gholi
Publikováno v:
Urology Journal, Vol 4, Iss 3, Pp 155-158 (2007)
Introduction: For eligible patients with end-stage renal disease, the dialysis stage could be bypassed by preemptive kidney transplantation (PKT), when the organ is available. We compared this treatment option with kidney transplantation in patients
Externí odkaz:
https://doaj.org/article/a2e4066852674bbb9abd94953f00c6a2
Publikováno v:
Iranian journal of kidney diseases. 14(2)
End-stage renal disease (ESRD) is a foremost health issue with major consequences in various parts of the world. In Iran, the prevalence/incidence of ESRD has increased during the past decades. The economic burden of ESRD treatment on patients, their
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::45ec4aab37bc0725051afb9e2caba9bd
https://pubmed.ncbi.nlm.nih.gov/32165593
https://pubmed.ncbi.nlm.nih.gov/32165593
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Iranian Red Crescent Medical Journal.
Background: Mineral bone disorder is one of the major factors affecting mortality and morbidity in dialysis patients, which is called chronic kidney disease-mineral and bone disorder (CKD-MBD). Objectives: This study aimed to evaluate the laboratory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22ee2ba49df4336eb32aedcd6e073d4f
https://doi.org/10.5812/ircmj.68772
https://doi.org/10.5812/ircmj.68772
Publikováno v:
Nephro-Urology Monthly.
Background: Anemia resistant to erythropoietin stimulating agents (ESAs) is a risk factor for all-cause mortality. Determining the etiologies of hyporesponsiveness may help overcome the resistance. We investigated the contributing factors in a popula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::305b673d17043c8aa711173ec1138a9f
https://doi.org/10.5812/numonthly.45003
https://doi.org/10.5812/numonthly.45003
Autor:
Nafar, Mohsen1,2, Abdei, Behrang Alipour1 alipour@ijkd.org, Ahmadpoor, Pedram1,2, Pour-Reza-Gholi, Fatemeh1,2, Samadian, Fariba1,2, Farhangi, Soudabeh1
Publikováno v:
Iranian Journal of Kidney Diseases. Jan2012, Vol. 6 Issue 1, p44-48. 5p. 1 Chart.
Publikováno v:
Nephro-Urology Monthly. 9
Background: Adequate dialysis improves patients’ outcome. Single pool Kt/V (spKt/V) > 1.4 is recommended as an index of adequacy. In this study, we assessed dialysis adequacy, the etiologies of under dialysis and the solutions. Methods: In a multic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a51bfcf5c1655a60ff5858601b2d6575
https://doi.org/10.5812/numonthly.42769
https://doi.org/10.5812/numonthly.42769
Publikováno v:
Iranian journal of kidney diseases. 11(1)
Both anemia and high doses of erythropoietin have been associated with increased mortality among dialysis patients. This study was conducted to evaluate the effective dose of erythropoiesis-stimulating agents.This multicenter nationwide cross-section
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b915974f4d4f9836ee76e87e127959a3
https://pubmed.ncbi.nlm.nih.gov/28174354
https://pubmed.ncbi.nlm.nih.gov/28174354
Autor:
Arash Tehrani Banihashemi, Alireza Khabazi, Fereydoun Davatchi, Mehrzad Hadj-Aliloo, Bozorgmehr Arabzadeh, Amir Salari, Kamal Essalat-Manesh, Farhad Shahram, Mohammed Hossein Forouzanfar, Jaleh Gholami, Abdolhadi Nadji, Behrang Alipour, Mansoor Salessi, Maziar Moradi, Massoomeh Akhlaghi, Mansoor Karimifar, Ahmadreza Jamshidi
Publikováno v:
APLAR Journal of Rheumatology. 10:239-243
Aim: To elucidate the prevalence of Behcet's disease (BD) during the World Health Organization-International League of Associations for Rheumatology Community Oriented Program for Control of Rheumatic Disease study in Iran. The old estimate was 16 pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f70bf0c55fc8b5399a824f05ef0ab0f
https://doi.org/10.1111/j.1479-8077.2007.00295.x
https://doi.org/10.1111/j.1479-8077.2007.00295.x
Autor:
Mohsen, Nafar, Behrang, Alipour, Pedram, Ahmadpoor, Fatemeh, Pour-Reza-Gholi, Fariba, Samadian, Shiva, Samavat, Soudabeh, Farhangi
Publikováno v:
Iranian journal of kidney diseases. 6(4)
Sirolimus is the one of new immunosuppressants that may be a substitute to traditional drugs such as cyclosporine. We present our investigation on sirolimus-based immunosuppression in kidney transplant recipients as compared with cyclosporine-based i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::46bfc1c5fad523d7a597c26ee3e5b9d8
https://pubmed.ncbi.nlm.nih.gov/22797101
https://pubmed.ncbi.nlm.nih.gov/22797101